Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Cullen

Showing results (131-140 of 165) with videos related to

Pageof 17
Sort By:
Urologic Oncology|March 7, 2020
A prospective analysis of health-related quality of life in intermediate and high-risk prostate cancer patients managed with intensity modulated radiation therapy, with vs. without hormonal therapyFernando Caumont, Galen Conti, Lauren M Hurwitz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 11, 2025
Dietary Iron Intake and Risk of Gastric CancerYen Thi-Hai Pham, Bac Nhi Nguyen, Thinh Gia Nguyen, et al.
Radiology|April 13, 2021
Prognostic Features of Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy Based on Multiparametric MRI and Immunohistochemistry Analysis of MRI-guided Biopsy SpecimensStephanie A Harmon, William Gesztes, Denise Young, et al.
Urology|January 3, 2016
Patient-specific Meta-analysis of 2 Clinical Validation Studies to Predict Pathologic Outcomes in Prostate Cancer Using the 17-Gene Genomic Prostate ScoreTimothy C Brand, Nan Zhang, Michael R Crager, et al.
The Journal of Urology|April 19, 2021
Cardiovascular Events in Men with Prostate Cancer Receiving Hormone Therapy: An Analysis of the FDA Adverse Event Reporting System (FAERS)Kathleen W Zhang, Melissa A Reimers, Adam Christopher Calaway, et al.
Cancer Biology & Therapy|June 15, 2007
Silencing of Lactotransferrin expression by methylation in prostate cancer progressionSyed Shaheduzzaman, Anu Vishwanath, Bungo Furusato, et al.
Journal of the National Cancer Institute|February 26, 2026
Leveraging the national cancer institute's collaborative efforts to understand the benefits and harms of cannabis use among individuals with cancerShannon M Nugent, Rebecca L Ashare, Jennifer Cullen, et al.
Journal of the American Heart Association|July 9, 2024
Allostatic Load/Chronic Stress and Cardiovascular Outcomes in Patients Diagnosed With Breast, Lung, or Colorectal CancerNickolas Stabellini, Jennifer Cullen, Marcio S Bittencourt, et al.
JCO Oncology Practice|May 29, 2026
Development and External Validation of a Machine Learning-Based Risk Classification Score for Prostate Cancer-Specific Cardiovascular RiskNickolas Stabellini, Tarek Nahle, Viraj Shah, et al.
Nutrients|April 14, 2026
Dietary Lycopene Intake and Gastric Cancer Risk: Findings from a Case-Control StudyNgoan Tran Le, Yen Thi-Hai Pham, Linh Thuy Le, et al.
Pageof 17

Showing results (131-140 of 165) with videos related to

Sort By:
Pageof 17
Urologic Oncology|March 7, 2020
A prospective analysis of health-related quality of life in intermediate and high-risk prostate cancer patients managed with intensity modulated radiation therapy, with vs. without hormonal therapyFernando Caumont, Galen Conti, Lauren M Hurwitz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 11, 2025
Dietary Iron Intake and Risk of Gastric CancerYen Thi-Hai Pham, Bac Nhi Nguyen, Thinh Gia Nguyen, et al.
Radiology|April 13, 2021
Prognostic Features of Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy Based on Multiparametric MRI and Immunohistochemistry Analysis of MRI-guided Biopsy SpecimensStephanie A Harmon, William Gesztes, Denise Young, et al.
Urology|January 3, 2016
Patient-specific Meta-analysis of 2 Clinical Validation Studies to Predict Pathologic Outcomes in Prostate Cancer Using the 17-Gene Genomic Prostate ScoreTimothy C Brand, Nan Zhang, Michael R Crager, et al.
The Journal of Urology|April 19, 2021
Cardiovascular Events in Men with Prostate Cancer Receiving Hormone Therapy: An Analysis of the FDA Adverse Event Reporting System (FAERS)Kathleen W Zhang, Melissa A Reimers, Adam Christopher Calaway, et al.
Cancer Biology & Therapy|June 15, 2007
Silencing of Lactotransferrin expression by methylation in prostate cancer progressionSyed Shaheduzzaman, Anu Vishwanath, Bungo Furusato, et al.
Journal of the National Cancer Institute|February 26, 2026
Leveraging the national cancer institute's collaborative efforts to understand the benefits and harms of cannabis use among individuals with cancerShannon M Nugent, Rebecca L Ashare, Jennifer Cullen, et al.
Journal of the American Heart Association|July 9, 2024
Allostatic Load/Chronic Stress and Cardiovascular Outcomes in Patients Diagnosed With Breast, Lung, or Colorectal CancerNickolas Stabellini, Jennifer Cullen, Marcio S Bittencourt, et al.
JCO Oncology Practice|May 29, 2026
Development and External Validation of a Machine Learning-Based Risk Classification Score for Prostate Cancer-Specific Cardiovascular RiskNickolas Stabellini, Tarek Nahle, Viraj Shah, et al.
Nutrients|April 14, 2026
Dietary Lycopene Intake and Gastric Cancer Risk: Findings from a Case-Control StudyNgoan Tran Le, Yen Thi-Hai Pham, Linh Thuy Le, et al.
Pageof 17